ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors

Journal of the National Cancer Institute

Volumn 103, Issue 4, 2011, Pages 317-333

  Dasgupta, Piyali ^c   Rizwani, Wasia ^a   Pillai, Smitha ^a   Davis, Rebecca ^a   Banerjee, Sarmistha ^a   Hug, Kevin ^b   Lloyd, Mark ^a   Coppola, Domenico ^a   Haura, Eric ^a   Chellappan, Srikumar P ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 1; CELL CYCLE PROTEIN 6; E1A ASSOCIATED P300 PROTEIN; MESSENGER RNA; NICOTINE; SHORT HAIRPIN RNA; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR E2F;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL EXAMINATION; CONTROLLED STUDY; GENE SILENCING; GENE TARGETING; GENETIC REGULATION; GENETIC TRANSFECTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MITOGENICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SURVIVAL; TISSUE MICROARRAY; TUMOR GROWTH;

APOPTOSIS; ARRESTINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; E2F TRANSCRIPTION FACTORS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUNG; LUNG NEOPLASMS; MICROSCOPY, CONFOCAL; NICOTINE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING; UP-REGULATION;

EID: 79951923011     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq541     Document Type: Article

References (72)

1. Johnson BE. Tobacco and lung cancer. Prim Care. 1998;25(2):279-291.
2. American Cancer Society. Cancer Facts and Figures.: Atlanta, GA: ACS; 2002.
3. Schuller HM, Orloff M. Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem Pharmacol. 1998;55(9):1377-1384. (Pubitemid 28298517)
4. Schuller HM, Jull BA, Sheppard BJ, Plummer HK. Interaction of tobacco-specific toxicants with the neuronal α7 nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders. Eur J Pharmacol. 2000;393(1-3):265-277. (Pubitemid 30193426)
5. West KA, Brognard J, Clark AS, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest. 2003;111(1):81-90. (Pubitemid 36134851)
6. Zhou H, Calaf GM, Hei TK. Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone. Int J Cancer. 2003;106(6):821-826. (Pubitemid 37071659)
7. Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A. 2006;103(16):6332-6337.
8. Manackjee R, Minna JD. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci U S A. 1990;87(9):3294-3298.
9. Charpantier E, Wiesner A, Huh KH, et al. Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. J Neurosci. 2005;25(43):9836-9849. (Pubitemid 41528021)
10. Mohamed AS, Swope SL. Phosphorylation and cytoskeletal anchoring of the acetylcholine receptor by Src class protein-tyrosine kinases. Activation by rapsyn. J Biol Chem. 1999;274(29):20529-20539.
11. Kumar P, Meizel S. Nicotinic acetylcholine receptor subunits and associated proteins in human sperm. J Biol Chem. 2005;280(27):25928-25935. (Pubitemid 40962306)
12. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004;74(6):363-396. (Pubitemid 40092737)
13. Itier V, Bertrand D. Neuronal nicotinic receptors: from protein structure to function. FEBS Lett. 2001;504(3):118-125. (Pubitemid 32787059)
14. Lindstrom J. Neuronal nicotinic acetylcholine receptors. In: Narahashi T, ed. Ion Channels. New York, NY: Plenum Press; 1996:377-450.
15. Dasgupta P, Rastogi S, Pillai S, et al. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest. 2006;116(8):2208-2217. (Pubitemid 44162330)
16. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science. 2005;308(5721):512-517.
17. Lefkowitz RJ, Whalen EJ. Beta-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol. 2004;16(2):162-168. (Pubitemid 38757292)
18. Ahn S, Nelson CD, Garrison TR, Miller WE, Lefkowitz RJ. Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference. Proc Natl Acad Sci U S A. 2003;100(4):1740-1744. (Pubitemid 36254518)
19. Mukherjee A, Veraksa A, Bauer A, Rosse C, Camonis J, Artavanis-Tsakonas S. Regulation of Notch signalling by non-visual beta-arrestin. Nat Cell Biol. 2005;7(12):1191-1201.
20. Rosano L, Cianfrocca R, Masi S, et al. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci U S A. 2009;106(8):2806-2811.
21. Chen W, ten Berge D, Brown J, et al. Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science. 2003;301(5638):1391-1394. (Pubitemid 37075817)
22. Chen W, Ren XR, Nelson CD, et al. Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science. 2004;306(5705):2257- 2260. (Pubitemid 40024463)
23. Wilbanks AM, Fralish GB, Kirby ML, Barak LS, Li YX, Caron MG. Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway. Science. 2004;306(5705):2264-2267. (Pubitemid 40024465)
24. Luttrell LM, Ferguson SS, Daaka Y, et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 1999;283(5402):655-661.
25. Shenoy SK, Drake MT, Nelson CD, et al. Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem. 2006;281(2):1261-1273.
26. Li TT, Alemayehu M, Aziziyeh AI, et al. Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res. 2009;7(7):1064-1077.
27. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A. 2006;103(5):1492-1497. (Pubitemid 43191193)
28. Galliera E, Jala VR, Trent JO, et al. Beta-arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem. 2004;279(24):25590-25597. (Pubitemid 38756820)
29. Tilley DG, Kim IM, Patel PA, Violin JD, Rockman HA. Beta-arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling. J Biol Chem. 2009;284(30):20375-20386.
30. Kang J, Shi Y, Xiang B, et al. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell. 2005;123(5):833-847. (Pubitemid 41721030)
31. Ma L, Pei G. Beta-arrestin signaling and regulation of transcription. J Cell Sci. 2007;120(Pt 2):213-218.
32. Lakshmikanthan V, Zou L, Kim JI, et al. Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer. Proc Natl Acad Sci U S A. 2009;106(23):9379-9384.
33. Chun KS, Lao HC, Trempus CS, Okada M, Langenbach R. The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development. Carcinogenesis. 2009;30(9):1620-1627.
34. Beaulieu JM, Caron MG. Beta-arrestin goes nuclear. Cell. 2005;123(5):755-757.
35. Hallstrom TC, Nevins JR. Balancing the decision of cell proliferation and cell fate. Cell Cycle. 2009;8(4):532-535.
36. Sun A, Bagella L, Tutton S, Romano G, Giordano A. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell Biochem. 2007;102(4):1400-1404. (Pubitemid 350223943)
37. van den Heuvel S, Dyson NJ. Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol. 2008;9(9):713-724.
38. Kinkade R, Dasgupta P, Carie A, et al. A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice. Cancer Res. 2008;68(10):3810-3818.
39. Dasgupta P, Sun J, Wang S, et al. Disruption of the Rb-Raf-1 interaction inhibits tumor growth and angiogenesis. Mol Cell Biol. 2004;24(21):9527-9541. (Pubitemid 39391689)
40. Wang S, Ghosh RN, Chellappan SP. Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation. Mol Cell Biol. 1998;18(12):7487-7498. (Pubitemid 28533067)
41. Rastogi S, Joshi B, Fusaro G, Chellappan S. Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism. J Biol Chem. 2006;281(5):2951-2959. (Pubitemid 43845762)
42. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res. 1983;11(5):1475-1489.
43. Dignam JD, Martin PL, Shastry BS, Roeder RG. Eukaryotic gene transcription with purified components. In: Methods Enzymol. Maryland Heights, MO: Elsevier; 1983:582-598. (Pubitemid 13071071)
44. Sanchez ER, Hu JL, Zhong S, Shen P, Greene MJ, Housley PR. Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock. Mol Endocrinol. 1994;8(4):408-421. (Pubitemid 24114731)
45. Rastogi S, Joshi B, Dasgupta P, Morris M, Wright K, Chellappan S. Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes. Mol Cell Biol. 2006;26(11):4161-4171. (Pubitemid 43788018)
46. Davis R, Rizwani W, Banerjee S, et al. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One. 2009;4(10):e7524.
47. Klein M, Vignaud JM, Hennequin V, et al. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):656-658. (Pubitemid 32207476)
48. Heeschen C, Weis M, Aicher A, Dimmler S, Cooke JP. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest. 2002;110(4):527-536. (Pubitemid 34919707)
49. Dasgupta P, Chellappan SP. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle. 2006;5(20):2324-2328. (Pubitemid 44801377)
50. West KA, Linnoila IR, Belinsky SA, Harris CC, Dennis PA. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3′-kinase/Akt pathway in vitro and in vivo. Cancer Res. 2004;64(2):446-451. (Pubitemid 38120880)
51. Schuller HM, Plummer HKIII, Jull BA. Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells. Anat Rec. 2003;270A(1):51-58. (Pubitemid 37243456)
52. Lefkowitz RJ, Rajagopal K, Whalen EJ. New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell. 2006;24(5):643-652. (Pubitemid 44839219)
53. Dasgupta P, Betts V, Rastogi S, et al. Direct binding of apoptosis signal-regulating kinase 1 to retinoblastoma protein: novel links between apoptotic signaling and cell cycle machinery. J Biol Chem. 2004;279(37):38762- 38769. (Pubitemid 39296034)
54. Wang S, Nath N, Fusaro G, Chellappan S. Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol. 1999;19(11):7447-7460. (Pubitemid 29493408)
55. Polager S, Ginsberg D. E2F - at the crossroads of life and death. Trends Cell Biol. 2008;18(11):528-535.
56. Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci. 2008;29(3):151-158.
57. Lindstrom JM. Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. New York: New York Academy of Sciences; 2003;998:41-52.
58. Cook JP, Bitterman H. Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med. 2004;36(1):33-40. (Pubitemid 38230697)
59. Brunton VG, Frame MC. Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol. 2008;8(4):427-432.
60. Sarker D, Reid AH, Yap TA, de Bono JS. Targeting the PI3K/AKT pathway for the treatment of prostate cancer. Clin Cancer Res. 2009;15(15):4799-4805.
61. Neuhaus EM, Mashukova A, Barbour J, Wolters D, Hatt H. Novel function of beta-arrestin2 in the nucleus of mature spermatozoa. J Cell Sci. 2006;119(Pt 15):3047-3056. (Pubitemid 44322119)
62. Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J. 2000;19(4):662-671. (Pubitemid 30093739)
63. Ozaki T, Okoshi R, Sang M, Kubo N, Nakagawara A. Acetylation status of E2F-1 has an important role in the regulation of E2F-1-mediated transactivation of tumor suppressor p73. Biochem Biophys Res Commun. 2009;386(1):207-211.
64. Daury L, Chailleux C, Bonvallet J, Trouche D. Histone H3.3 deposition at E2F-regulated genes is linked to transcription. EMBO Rep. 2006;7(1):66-71.
65. Pillai S, Kovacs M, Chellappan S. Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation. Cancer Res. 2010;70(12):4931-4940.
66. Trombino S, Bisio A, Catassi A, Cesario A, Falugi C, Russo P. Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategies. Curr Med Chem Anticancer Agents. 2004;4(6):535-542. (Pubitemid 39406265)
67. Trombino S, Cesario A, Margaritora S, et al. Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res. 2004;64(1):135-145. (Pubitemid 38114091)
68. Catassi A, Servent D, Paleari L, Cesario A, Russo P. Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat Res. 2008;659(3):221-231.
69. Dasgupta P, Rizwani W, Pillai S, et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer. 2009;124(1):36-45.
70. Paleari L, Catassi A, Ciarlo M, et al. Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation. Cell Prolif. 2008;41(6):936-959.
71. Paleari L, Cesario A, Fini M, Russo P. Alpha7-nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma? Drug Discov Today. 2009;14(17-18):822-836.
72. Paleari L, Grozio A, Cesario A, Russo P. The cholinergic system and cancer. Semin Cancer Biol. 2008;18(3):211-217.